5. Conclusion
It seems that, after a phase of enthusiasm for the development of nanoparticles, we are now witnessing a slowdown in the development of these health objects. The future of these objects will undoubtedly lie in the optimization of 3rd-generation nanoparticles, enabling effective targeting of cells (conjugated active ingredients and antibodies), the tissue of interest and/or opening up new therapeutic indications. . These objects are widely used to treat cancer, where the benefit/risk balance can tolerate certain side effects. The current "safer-by-design" approach aims in particular (but not exclusively) to design safer or less toxic nanoparticles...
Exclusive to subscribers. 97% yet to be discovered!
You do not have access to this resource.
Click here to request your free trial access!
Already subscribed? Log in!
The Ultimate Scientific and Technical Reference
This article is included in
Drugs and pharmaceuticals
This offer includes:
Knowledge Base
Updated and enriched with articles validated by our scientific committees
Services
A set of exclusive tools to complement the resources
Practical Path
Operational and didactic, to guarantee the acquisition of transversal skills
Doc & Quiz
Interactive articles with quizzes, for constructive reading
Conclusion
Bibliography
Standards and norms
- Nanotechnologies, guidance on physicochemical characterization of engineered nanoscale materials for toxicological assessment. - ISO/TR-13014 :2012 - 2012
- Nanotechnologies – Measurements Technique Matrix for the Characterization of Nano-Objects. ISO. - ISO/TR-18196 :2016 - 2016
- Nanotechnologies – Terminology and definitions for nano-objects, nanoparticle, nanofibre and nanoplate. - ISO/TS - 2008
- Particle...
Exclusive to subscribers. 97% yet to be discovered!
You do not have access to this resource.
Click here to request your free trial access!
Already subscribed? Log in!
The Ultimate Scientific and Technical Reference